|
Volumn 58, Issue 1, 2009, Pages 3-4
|
After budesonide, what next for collagenous colitis?
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOSALICYLIC ACID;
AZATHIOPRINE;
BISMUTH SALICYLATE;
BUDESONIDE;
CALCIUM;
COLESTYRAMINE;
GLUTEN;
PLACEBO;
VITAMIN D;
ANTIINFLAMMATORY AGENT;
GLUCOCORTICOID;
CALCIUM INTAKE;
CATARACT;
CELIAC DISEASE;
CLINICAL TRIAL;
COLLAGENOUS COLITIS;
DIABETES MELLITUS;
DISEASE COURSE;
DISEASE DURATION;
DRUG DEPENDENCE;
DRUG EFFICACY;
DRUG MONITORING;
DRUG TOLERABILITY;
EDEMA;
EXERCISE;
FOLLOW UP;
GLAUCOMA;
GLUTEN FREE DIET;
HUMAN;
HYPERTENSION;
LONG TERM CARE;
LYMPHOCYTIC COLITIS;
MAINTENANCE DRUG DOSE;
MAINTENANCE THERAPY;
METABOLIC BONE DISEASE;
NOTE;
PRIORITY JOURNAL;
RECURRENCE RISK;
RELAPSE;
REMISSION;
SHORT COURSE THERAPY;
TREATMENT DURATION;
TREATMENT RESPONSE;
TREATMENT WITHDRAWAL;
UNSPECIFIED SIDE EFFECT;
VERNER MORRISON SYNDROME;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS;
BUDESONIDE;
COLITIS, COLLAGENOUS;
GLUCOCORTICOIDS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECURRENCE;
TREATMENT OUTCOME;
|
EID: 58249086013
PISSN: 00175749
EISSN: 14683288
Source Type: Journal
DOI: 10.1136/gut.2008.163477 Document Type: Note |
Times cited : (25)
|
References (11)
|